140 related articles for article (PubMed ID: 35241527)
1. Significance of HER2 and VEGFR2 in Early-stage Endometrial Cancer.
An HJ; Song DH; Kim YM; Jo HC; Baek JC; Park JE
In Vivo; 2022; 36(2):723-730. PubMed ID: 35241527
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.
Wang J; Taylor A; Showeil R; Trivedi P; Horimoto Y; Bagwan I; Ewington L; Lam EW; El-Bahrawy MA
Cytokine; 2014 Aug; 68(2):94-100. PubMed ID: 24845798
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
[TBL] [Abstract][Full Text] [Related]
5. A study of HER2 expression in endometrial carcinoma: a single centre experience.
Hashim M; Tizen NMS; Alfian N; Hashim H; Nawi AM; Pauzi SHM
Pan Afr Med J; 2021; 38():200. PubMed ID: 33995806
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II.
Skirnisdottir I; Åkerud H; Seidal T
Int J Oncol; 2018 Oct; 53(4):1633-1642. PubMed ID: 30066848
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
Rydén L; Jirström K; Haglund M; Stål O; Fernö M
Breast Cancer Res Treat; 2010 Apr; 120(2):491-8. PubMed ID: 20135347
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
9. HER2-positive endometrial cancer subtype carries poor prognosis.
Lapińska-Szumczyk S; Supernat A; Majewska H; Gulczyński J; Luczak A; Biernat W; Wydra D; Zaczek AJ
Clin Transl Sci; 2014 Dec; 7(6):482-8. PubMed ID: 25201050
[TBL] [Abstract][Full Text] [Related]
10. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
12. Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.
Tessneer KL; Pasula S; Cai X; Dong Y; McManus J; Liu X; Yu L; Hahn S; Chang B; Chen Y; Griffin C; Xia L; Adams RH; Chen H
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):331-337. PubMed ID: 24311377
[TBL] [Abstract][Full Text] [Related]
13. Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma.
An HJ; Song DH; Koh HM; Kim YM; Ko GH; Lee JH; Lee JS; Yang JW; Kim MH; Seo DH; Jang SM; Kim DC
Sci Rep; 2019 Sep; 9(1):12656. PubMed ID: 31477752
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.
Dobrzycka B; Terlikowski SJ; Kwiatkowski M; Garbowicz M; Kinalski M; Chyczewski L
Ginekol Pol; 2010 Jun; 81(6):422-5. PubMed ID: 20695190
[TBL] [Abstract][Full Text] [Related]
15. Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
Goussia A; Simou N; Zagouri F; Manousou K; Lazaridis G; Gogas H; Koutras A; Sotiropoulou M; Pentheroudakis G; Bafaloukos D; Markopoulos C; Patsea H; Christodoulou C; Papakostas P; Zaramboukas T; Samantas E; Kosmidis P; Venizelos V; Karanikiotis C; Papatsibas G; Xepapadakis G; Kalogeras KT; Bamia C; Dimopoulos MA; Malamou-Mitsi V; Fountzilas G; Batistatou A
PLoS One; 2018; 13(7):e0200302. PubMed ID: 30063723
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer.
Chen HY; Zhou ZY; Luo YL; Luo Q; Fan JT
Cell Biol Int; 2021 Dec; 45(12):2557-2566. PubMed ID: 34498339
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
[TBL] [Abstract][Full Text] [Related]
19. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tyrosine kinase receptors HER2, EGFR, and VEGFR expression in micropapillary urothelial carcinoma with invasive urothelial carcinoma.
Li J; Jackson CL; Yang D; Noble L; Wheeler M; MacKenzie D; Adegun T; Amin A
Target Oncol; 2015 Sep; 10(3):355-63. PubMed ID: 25293577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]